The effects of sevelamer carbonate on blood glucose and inflammatory factors in patients with diabetic kidney disease; a controlled clinical trial
Introduction: Diabetic nephropathy (diabetic kidney disease) is a complication of diabetes that begins and progresses with several factors, including hyperglycemia, inflammation and oxidative stress. Objective: This study demonstrates the effect of sevelamer carbonate administration on hemoglobin A1...
Main Authors: | Shadi Botshekan, Leila Mahmoodnia, Ali Momeni, Tina Jafari, Ali Hasanpour Dehkordi, Mohammadsaleh Ghafari Goosheh |
---|---|
Format: | Article |
Language: | English |
Published: |
Society of Diabetic Nephropathy Prevention
2021-05-01
|
Series: | Journal of Nephropharmacology |
Subjects: | |
Online Access: | https://jnephropharmacology.com/PDF/npj-10351 |
Similar Items
-
Phosphate binders in chronic kidney disease: The positions of sevelamer
by: V V Fomin, et al.
Published: (2013-06-01) -
Meta-analysis of the efficacy and safety of sevelamer as hyperphosphatemia therapy for hemodialysis patients
by: Qian Zeng, et al.
Published: (2023-12-01) -
Sevelamer Use in End-Stage Kidney Disease (ESKD) Patients Associates with Poor Vitamin K Status and High Levels of Gut-Derived Uremic Toxins: A Drug–Bug Interaction?
by: Lu Dai, et al.
Published: (2020-05-01) -
Sevelamer-associated ischemic colitis with perforation
by: Rachel Hudacko, et al.
Published: (2015-12-01) -
Effect of sevelamer on serum phosphorus levels in chronic kidney disease and hemodialysis patients; a systematic review and meta-analysis
by: Farshad Gharebakhshi, et al.
Published: (2024-01-01)